Bristol-Myers Squibb (BMY) – Management Comments
-
Bristol-Myers Squibb tops Q4 expectations, reports strong anemia drug sales
-
Bristol Myers expects to launch 16 new products through 2030 - CEO
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BMY Stock Lookup